Allegro Ophthalmics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $23.9M
Latest Deal Amount
  • Investors
  • 2

Allegro Ophthalmics General Information

Description

Developer of ophthalmic drugs designed for the treatment of wet age-related macular degeneration. The company provides treatment for neovascular eye diseases including age-related macular degeneration, diabetic retinopathy and diabetic macular edema, enabling patients to stay healthier for longer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 31473 Rancho Viejo Road
  • Suite 204
  • San Juan Capistrano, CA 92675
  • United States
+1 (949) 000-0000

Allegro Ophthalmics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Allegro Ophthalmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Oct-2020 $23.9M 000.00 Completed Clinical Trials - Phase 1
4. Later Stage VC 09-Jul-2017 000.00 000.00 Completed Clinical Trials - Phase 1
3. Grant 03-Feb-2015 000 000.00 Completed Clinical Trials - Phase 1
2. Early Stage VC 26-Jan-2015 $20.3M $21.8M Completed Clinical Trials - Phase 1
1. Angel (individual) 01-Apr-2012 $1.5M $1.5M Completed Clinical Trials - Phase 1
To view Allegro Ophthalmics’s complete valuation and funding history, request access »

Allegro Ophthalmics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of ophthalmic drugs designed for the treatment of wet age-related macular degeneration. The company provides t
Pharmaceuticals
San Juan Capistrano, CA
10 As of 2020
000.00
0000000000 0 000.00

0000000

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000 000000000
Cambridge, United Kingdom
00 As of 0000
00.000
0.000 0000-00-00
0000000000 0 00.000

00000000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
Charlottesville, VA
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Allegro Ophthalmics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exonate Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 0 00.000
0000000000000 Venture Capital-Backed Charlottesville, VA 0 000.00 0000000000 0 000.00
000 000000000000 Venture Capital-Backed Ann Arbor, MI 00 000.00 0000000000 0 000.00
0000 000000000000 Angel-Backed Austin, TX 00.000 0000000000 00.000
000000000 Venture Capital-Backed Cumberland, RI 00 000.00 0000000000 000.00
To view Allegro Ophthalmics’s complete competitors history, request access »

Allegro Ophthalmics Executive Team (6)

Name Title Board Seat Contact Info
Vicken Karageozian MD Co-Founder & Chief Executive Officer
Scott Cooper Chief Financial Officer and Vice President of Business Development
John Park Ph.D Co-Founder, Chief Scientific Officer & Vice President of Product Development and Board Member
Hampar Karageozian Ph.D Co-Founder & Executive Chairman
You’re viewing 4 of 6 executive team members. Get the full list »

Allegro Ophthalmics Board Members (11)

Name Representing Role Since
Hampar Karageozian Ph.D Allegro Ophthalmics Co-Founder & Executive Chairman 000 0000
Marc Carlson Allegro Ophthalmics Board Member 000 0000
Mark Livingston Allegro Ophthalmics Board Member 000 0000
Rebecca Colbert Self Board Member 000 0000
Ronald Kurtz Allegro Ophthalmics Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Allegro Ophthalmics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allegro Ophthalmics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Leona M. and Harry B. Helmsley Charitable Trust Lender/Debt Provider 000 0000 000000 0
Hanmi Pharmaceuticals Corporation Minority 000 0000 000000 0
To view Allegro Ophthalmics’s complete investors history, request access »